Joseph E. Payne serves as Executive at Arcturus Therapeutics Holdings Inc., where they oversee executive responsibilities. Since joining the company, Joseph E. Payne has executed 5 insider transactions totaling $242.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 23, 2022 involved purchasing 5,000 shares valued at $82.5K.
Joseph E. Payne currently holds 1,480,097 shares of Arcturus Therapeutics Holdings Inc. (ARCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph E. Payne has been a net buyer of ARCT stock. They have purchased $242.1K and sold $0 worth of shares.
Joseph E. Payne's most recent insider trade was on Nov 23, 2022, when they purchased 5,000 shares at $16.51 per share.
Get notified when new Form 4 filings are submitted
| $4.50 |
| Discretionary |
| May 25, 2021 | VLON | $41.2K | Purchase | 10,700 | $3.85 | Discretionary |
| Jun 10, 2020 | ARCT | $31.7K | Purchase | 1,000 | $31.69 | Discretionary |
| Aug 29, 2019 | ARCT | $56.1K | Purchase | 5,000 | $11.22 | Discretionary |